Arcus BiosciencesRCUS
13F holders, Q2 2026 (June 30)231holders +20
43new positions
24sold out
5famous investors
$30.82avg. 13F price*
At the end of Q2 2026, 231 institutions reported holding Arcus Biosciences Inc. (RCUS) in their 13F filings, up 20 from Q1 2026. 43 opened new positions and 24 sold out. The largest holders were Gilead Sciences, Inc. ($968.8M), BlackRock, Inc. ($506.1M) and State Street Corp. ($185.9M). 5 famous investors held it, including Ken Griffin (0.1% of Citadel Advisors's portfolio), Ken Fisher (0.0% of Fisher Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Arcus Biosciences Inc.
- CUSIP
- 03969F109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 43 | $66.0M |
| Exits | 24 | $47.7M |
All 13F filers, Q1 2026 → Q2 2026: 12,961,437 shares bought and 9,390,339 shares sold, net +3,571,098 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 231 holders
| Gilead Sciences, Inc. | 58.76% | No change | 31,424,760 | $968.8M |
| BlackRock, Inc. | 0.01% | Add +7.8% | 16,416,249 | $506.1M |
| State Street Corp. | 0.01% | Add +11.4% | 6,029,484 | $185.9M |
| Wellington Management Group LLP | 0.03% | Reduce -3.2% | 5,895,448 | $181.8M |
| Montanova Capital, LLC | 3.09% | Reduce -5.1% | 4,776,423 | $147.3M |
| Vanguard Portfolio Management LLC | 0.01% | Add +4.8% | 4,475,528 | $138.0M |
| FMR LLC | 0.01% | Add +247.5% | 4,049,757 | $124.9M |
| Vanguard Capital Management LLC | 0.00% | Add +0.8% | 3,888,346 | $119.9M |
| Citadel Advisors | 0.06% | Add +135.7% | 3,135,057 | $96.7M |
| Woodline Partners LP | 0.29% | Reduce -20.4% | 3,007,798 | $92.7M |
| Geode Capital Management, LLC | 0.00% | Add +8.7% | 2,448,749 | $75.5M |
| Siren, L.L.C. | 1.51% | Reduce -19.5% | 2,420,430 | $74.6M |
| Fisher Asset Management | 0.02% | Reduce -2.3% | 2,139,396 | $66.0M |
| Marshall Wace, LLP | 0.05% | Reduce -48.3% | 1,945,088 | $60.0M |
| Samlyn Capital, LLC | 0.79% | Reduce -18.9% | 1,547,182 | $47.7M |
| Dimensional Fund Advisors LP | 0.01% | Add +0.6% | 1,434,320 | $44.2M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.04% | Reduce -14.2% | 1,419,533 | $43.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +38.8% | 1,387,566 | $42.8M |
| Soleus Capital Management, L.P. | 1.24% | Add +158.6% | 1,168,738 | $36.0M |
| Sofinnova Investments, Inc. | 1.56% | Add +2.5% | 945,690 | $29.2M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +4.2% | 941,756 | $29.0M |
| Northern Trust Corp. | 0.00% | Add +11.0% | 932,523 | $28.7M |
| Parkman Healthcare Partners LLC | 2.91% | Reduce -23.9% | 919,266 | $28.3M |
| Invesco Ltd. | 0.00% | Add +3.0% | 845,233 | $26.1M |
| Baker Bros. Advisors LP | 0.13% | Add +103.3% | 844,816 | $26.0M |
| Bank of America Corp. | 0.00% | Add +29.3% | 835,504 | $25.8M |
| Morgan Stanley | 0.00% | Reduce -28.5% | 795,912 | $24.5M |
| Candriam S.C.A. | 0.09% | Reduce -16.3% | 661,981 | $20.4M |
| Aberdeen Group plc | 0.03% | Reduce -15.5% | 650,712 | $20.1M |
| Logos Global Management LP | 0.86% | Reduce -45.8% | 650,000 | $20.0M |
| Two Sigma Investments, LP | 0.02% | Add +103.2% | 635,404 | $19.6M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +5.7% | 616,088 | $19.0M |
| T. Rowe Price Investment Management, Inc. | 0.01% | New | 589,546 | $18.2M |
| Bank of New York Mellon Corp | 0.00% | Add +6.2% | 543,009 | $16.7M |
| Jacobs Levy Equity Management, Inc. | 0.06% | Add +19.0% | 512,084 | $15.8M |
| Ikarian Capital, LLC | 2.55% | New | 504,559 | $15.6M |
| Decheng Capital LLC | 1.96% | Reduce -2.7% | 464,779 | $14.3M |
| DAFNA Capital Management LLC | 2.60% | Reduce -0.5% | 441,829 | $13.6M |
| JPMorgan Chase & Co. | 0.00% | Add +417.5% | 418,243 | $13.1M |
| Principal Financial Group Inc. | 0.01% | Add +2.3% | 423,366 | $13.1M |
| Nomura Asset Management International Inc. | 0.02% | No change | 379,100 | $11.7M |
| UBS Group AG | 0.00% | Add +27.8% | 369,056 | $11.4M |
| Patient Square Capital LP | 1.70% | Add +82.5% | 355,800 | $11.0M |
| PDT Partners, LLC | 0.52% | Reduce -16.7% | 323,567 | $10.0M |
| Public Sector Pension Investment Board | 0.02% | Reduce -1.7% | 298,156 | $9.2M |
| First Trust Advisors LP | 0.00% | Add +1972.3% | 271,434 | $8.4M |
| Nuveen, LLC | 0.00% | Add +5.6% | 234,052 | $7.2M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | Reduce -20.1% | 225,008 | $6.9M |
| Diadema Partners LP | 2.61% | Reduce -6.0% | 223,810 | $6.9M |
| Rhumbline Advisers | 0.01% | Reduce -9.2% | 219,181 | $6.8M |
| Ensign Peak Advisors, Inc | 0.01% | Reduce -14.8% | 215,613 | $6.6M |
| Legal & General Group Plc | 0.00% | Add +1.5% | 191,560 | $5.9M |
| Rock Springs Capital Management LP | 0.27% | No change | 180,000 | $5.5M |
| Swiss National Bank | 0.00% | Add +2.8% | 176,096 | $5.4M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -2.5% | 154,398 | $4.8M |
| Boothbay Fund Management, LLC | 0.09% | New | 154,264 | $4.8M |
| Ameriprise Financial Inc. | 0.00% | Reduce -3.9% | 153,813 | $4.7M |
| BNP Paribas Financial Markets | 0.00% | Reduce -59.9% | 153,109 | $4.7M |
| PFM Health Sciences, LP | 0.41% | New | 152,129 | $4.7M |
| Hudson Bay Capital Management LP | 0.02% | Reduce -60.7% | 140,000 | $4.3M |
| Man Group plc | 0.01% | Add +70.4% | 137,763 | $4.2M |
| Platinum Investment Management Ltd. | 1.02% | No change | 134,217 | $4.1M |
| Millennium Management | 0.00% | New | 133,110 | $4.1M |
| Schonfeld Strategic Advisors LLC | 0.02% | Reduce -36.7% | 122,574 | $3.8M |
| Citigroup Inc. | 0.00% | Add +325.2% | 112,238 | $3.5M |
| Sectoral Asset Management Inc. | 2.39% | Add +146.0% | 110,870 | $3.4M |
| Prudential Financial Inc. | 0.00% | Add +25.7% | 110,603 | $3.4M |
| California State Teachers Retirement System | 0.00% | Reduce -7.9% | 97,410 | $3.0M |
| D. E. Shaw & Co. | 0.00% | Reduce -62.8% | 96,417 | $3.0M |
| Deutsche Bank AG | 0.00% | Add +28.3% | 94,710 | $2.9M |
| New York State Teachers Retirement System | 0.01% | Add +3.1% | 92,431 | $2.9M |
| T. Rowe Price Associates Inc. | 0.00% | Add +17.7% | 89,202 | $2.8M |
| Alliancebernstein L.P. | 0.00% | Add +2.3% | 126,975 | $2.7M |
| Parallel Advisors, LLC | 0.04% | No change | 86,557 | $2.7M |
| Odyssean, LLC | 0.43% | New | 85,497 | $2.6M |
| Tidal Investments LLC | 0.01% | Reduce -1.4% | 85,126 | $2.6M |
| AQR Capital Management | 0.00% | Reduce -2.8% | 83,861 | $2.6M |
| Tema ETFs LLC | 0.08% | Add +10.5% | 83,140 | $2.6M |
| Wells Fargo & Company | 0.00% | Add +132.1% | 82,913 | $2.6M |
| Allianz Asset Management GmbH | 0.00% | New | 82,458 | $2.5M |
| State of Wisconsin Investment Board | 0.01% | Add +39.2% | 82,399 | $2.5M |
| Jump Financial, LLC | 0.02% | Reduce -39.6% | 82,036 | $2.5M |
| Russell Investments Group, Ltd. | 0.00% | Add +0.9% | 81,549 | $2.5M |
| Knott David M Jr | 1.32% | No change | 81,241 | $2.5M |
| Thrivent Financial for Lutherans | 0.00% | Add +12.7% | 78,718 | $2.4M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -37.7% | 71,725 | $2.2M |
| CANADA LIFE ASSURANCE Co | 0.00% | No change | 70,518 | $2.2M |
| VANGUARD ASSET MANAGEMENT, Ltd | 0.00% | Add +13.6% | 63,528 | $2.0M |
| Caption Management, LLC | 0.07% | Add +286.7% | 62,000 | $1.9M |
| Fred Alger Management, LLC | 0.01% | New | 60,494 | $1.9M |
| BIT Capital GmbH | 0.06% | New | 60,000 | $1.8M |
| Corient Private Wealth LP | 0.00% | Add +144.9% | 59,127 | $1.8M |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Add +15.7% | 59,021 | $1.8M |
| Quantinno Capital Management LP | 0.00% | Add +231.1% | 57,255 | $1.8M |
| Persistent Asset Partners Ltd | 0.56% | Reduce -5.2% | 57,048 | $1.8M |
| Raymond James Financial Inc. | 0.00% | Add +42.1% | 53,680 | $1.7M |
| Susquehanna Portfolio Strategies, LLC | 0.03% | Reduce -77.6% | 53,668 | $1.7M |
| WINTON GROUP Ltd | 0.05% | Add +59.6% | 52,398 | $1.6M |
| MetLife Investment Management, LLC | 0.01% | Add +16.3% | 52,110 | $1.6M |
| Illinois Municipal Retirement Fund | 0.02% | Add +41.4% | 51,214 | $1.6M |
"% of holder's portfolio" is RCUS's weight in each manager's 13F, not the share of Arcus Biosciences Inc. the manager owns.